Helex Secures $3.5 Million in Seed Funding, Led by pi Ventures
Helex has raised $3.5 million to accelerate therapies for Autosomal Dominant Polycystic Kidney Disease.
Helex has raised $3.5 million to accelerate therapies for Autosomal Dominant Polycystic Kidney Disease.